홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 파머슈티컬 > 감염질환 > Strategic Analysis of the U.S. Hepatitis B and C Markets
카테고리
파머슈티컬 (4931)
감염질환 (349)
골질환 치료 (38)
당뇨병 (194)
백신 (181)
비만치료/다이어트 (44)
비처방 의약품 (152)
수의학 (17)
신경질환 (174)
신약개발 (1529)
암치료 (941)
약물전달 (185)
의약품 규제환경 (127)
정신질환 (86)
제네릭 의약품 (128)
제약회사분석 (523)
처방약 (165)
시장보고서

Strategic Analysis of the U.S. Hepatitis B and C Markets

리서치사 Frost & Sullivan
발행일 2006년 01월 상품코드 40437
페이지 정보
가격
US $ 3,950 ￦ 4,706,400 Web Access (Regional License)
US $ 4,450 ￦ 5,302,100 Hard Copy & Web Access (Regional License)


영문목차

Abstract

This Frost & Sullivan research service entitled Strategic Analysis of U.S. Hepatitis B and C Markets provides strategic recommendations and SWOT analysis, patient and pricing forecasts, market share analysis, and analysis of existing and new products. In this research, Frost & Sullivan's expert analysts thoroughly examine the Total Market along with the U.S. Hepatitis B and U.S. Hepatitis C Markets.

This analysis is available through our Pharmaceutical & Biotechnology Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

1. Executive Summary

  • 1. Executive Summary
    • 1. Executive Summary

2. Total Hepatitis Markets

  • 1. Market Overview
    • 1. Introduction
    • 2. Market Segmentation
    • 3. Research Methodology
  • 2. SWOT Analysis and Revenue Forecast
    • 1. SWOT Analysis
    • 2. Revenue Forecasts
  • 3. Industry Challenges and Strategies
    • 1. Industry Challenges
    • 2. Strategic Recommendations
  • 4. Frost and Sullivan Awards
    • 1. Entrepreneurial Company Award

3. U.S. Hepatitis B Market

  • 1. Market Overview
    • 1. Introduction
    • 2. Market Engineering Measurements
  • 2. Market Forecast and Trends
    • 1. Patient Forecast
    • 2. Pricing Forecast
    • 3. Revenue Forecast
    • 4. Market Trends
  • 3. Competitive Analysis
    • 1. Competitive Structure
    • 2. Market Share Analysis

4. U.S. Hepatitis C Market

  • 1. Market Overview
    • 1. Introduction
    • 2. Market Engineering Measurements
  • 2. Market Forecast
    • 1. Patient Forecast
    • 2. Pricing Forecast
    • 3. Revenue Forecast
    • 4. Market Trends
  • 3. Competitive Analysis
    • 1. Competitive Structure
    • 2. Market Share Analysis

5. Decision Support Databases

  • 1. Disease Incidence
    • 1. HIV Prevalence
    • 2. AIDS Incidence
    • 3. Hepatitis B Incidence
  • 2. Healthcare Expenditure
    • 1. Pharmaceutical R&D Expenditure
    • 2. Percentage Pharmaceutical R&D Expenditure
    • 3. Total Healthcare Expenditure
Back to Top